Posterior reversible encephalopathy syndrome as a complication of acute lupus activity

Clinical Neurology and Neurosurgery

Volumn 111, Issue 4, 2009, Pages 359-363

  Baizabal Carvallo, José Fidel ^a   Barragán Campos, Héctor Manuel ^b   Padilla Aranda, Héctor Javier ^a   Alonso Juarez, Marlene ^a   Estañol, Bruno ^a   Cantú Brito, Carlos ^a   García Ramos, Guillermo ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b INSTITUTO NACIONAL DE PEDIATRÍA   (Mexico)

Author keywords

Blood brain barrier; Disease Activity Index; Hypertension; Neuropsychiatric lupus; Posterior reversible encephalopathy syndrome; Systemic lupus erythematosus

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DEXAMETHASONE; HYDROCORTISONE; METHYLPREDNISOLONE; PREDNISONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; HYPERTENSION; KIDNEY FAILURE; MALE; NEUROIMAGING; NEUROLOGIC DISEASE; OUTCOME ASSESSMENT; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS; TERTIARY HEALTH CARE;

ADULT; BRAIN DISEASES, METABOLIC; CYCLOPHOSPHAMIDE; FEMALE; HUMANS; HYPERTENSION; LUPUS ERYTHEMATOSUS, SYSTEMIC; MAGNETIC RESONANCE IMAGING; MALE; RENAL INSUFFICIENCY; YOUNG ADULT;

EID: 63449094931     PISSN: 03038467     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clineuro.2008.11.017     Document Type: Article

References (26)

1. Hinchey J., Chaves C., Appignani B., Breen J., Pao L., Wang A., et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 334 (1996) 494-500
2. Jarosz J.M., Howlett D.C., Cox T.C., and Bingham J.B. Cyclosporine-related reversible posterior leukoencephalopathy: MRI. Neuroradiology 39 (1997) 711-715
3. Delanty N., Vaughan C., Frucht S., and Stubgen P. Erythropoietin-associated posterior leukoencephalopathy. Neurology 49 (1997) 686-689
4. Lanzino G., Cloft H., Hemstreet M.K., West K., Alston S., and Ishitani M. Reversible posterior leukoencephalopathy following organ transplantation. Description of two cases. Clin Neurol Neurosurg 99 (1997) 222-226
5. Ito Y., Niwa H., Iida T., Nagamatsu M., Yasuda T., Yanagi T., et al. Post-transfusion reversible posterior leukoencephalopathy syndrome with cerebral vasoconstriction. Neurology 49 (1997) 1174-1175
6. Ito Y., Arahata Y., Goto Y., Hirayama M., Nagamatsu M., Yasuda T., et al. Cisplatin neurotoxicity presenting as reversible posterior leukoencephalopathy syndrome. Am J Neuroradiol 19 (1998) 415-417
7. Van Diest D., Van Goethem J.W.M., Vercruyssen A., Jadoul C., and Cras P. Posterior reversible encephalopathy and Guillain-Barré syndrome in a single patient: coincidence or causative relation?. Clin Neurol Neurosurg 109 (2007) 58-62
8. Tan E.M., Cohen A.S., Fries J.F., Masi A.T., McShane D.J., Rothfield N.F., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25 (1982) 1271-1277
9. Bombardier C., Gladman D.D., Urowitz M.B., Caron D., Chang C.H., and and the Committee on Prognosis Studies in SLE. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 35 (1992) 630-640
10. Gladman D., Ginzler E., Goldsmith C., Fortin P., Liang M., Urowitz M., et al. The development and initial validation of the systemic lupus international collaborating clinics/American college of rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 39 (1996) 363-368
11. Wilson W.A., Gharavi A.E., Koike T., Lockshin M.D., Branch D.W., Piette J.C., et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 42 (1999) 1309-1311
12. McLean B.N., Miller D., and Thompson E.J. Oligoclonal banding of IgG in CSF, blood-brain barrier function, and MRI findings in patients with sarcoidosis, systemic lupus erythematosus, and Behçet's disease involving the nervous system. J Neurol Neurosurg Psychiatry 58 (1995) 548-554
13. Hurst R.D., and Fritz I.B. Properties of an immortalized vascular endothelial/glioma cell co-culture model of the blood brain barrier. J Cell Physiol 167 (1996) 81-88
14. Easton A.S., and Abbott N.J. Bradykinin increases permeability by calcium and 5-lipoxygenase in the ECV304/C6 cell culture model of the blood brain barrier. Brain Res 953 (2002) 157-169
15. Hurst R.D., and Fritz I.B. Nitric oxide-induced perturbations in a cell culture model of the blood-brain barrier. J Cell Physiol 167 (1996) 89-94
16. Hurst R.D., and Clark J.B. Alterations of transendothelial electrical resistance by vasoactive agonist and cyclic AMP in a blood-brain barrier model system. Neurochem Res 23 (1997) 149-154
17. Abbott N.J., Mendonça L.L.F., and Dolman D.E.M. The blood-brain barrier in systemic lupus erythematosus. Lupus 12 (2003) 908-915
18. Lee S.C., Dickson D.W., Liu W., and Brosnan C.F. Induction of nitric oxide synthase activity in human astrocytes by interleukin-1 beta and interferon-gamma. J Neuroimmunol 46 (1993) 19-24
19. Meroni P.L., Raschi E., Camera M., Testoni C., Nicoletti F., Tincani A., et al. Endothelial activation by aPL: a potential pathogenic mechanism for the clinical manifestations of the syndrome. J Autoimmunity 15 (2000) 237-240
20. Leroux G., Sellam J., Costedoat-Chalumeau N., Le Thi Huong D., Combes A., Tieulié N., et al. Posterior reversible encephalopathy syndrome during systemic lupus erythematosus: four new cases and review of the literature. Lupus 17 2 (2008) 139-147
21. Edvinson L., Owman C., and Siesjo B. Physiologic role of cerebrovascular sympathetic in the autoregulation of cerebral blood flow. Brain Res 117 (1976) 518-523
22. Casey S.O., Sampaio R.C., Michel R., and Truwitt C.L. Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions. Am J Neuroradiol 21 (2000) 1199-1206
23. Ay H., Buonanno F.S., Schaefer P.W., Le D.A., Wang B., Gonzalez R.G., et al. Posterior leukoencephalopathy without severe hypertension: utility of diffusion-weighted MRI. Neurology 51 (1998) 1369-1376
24. Chen S.P., Fuh J.L., Lirng J.F., and Wang S.J. Is vasospasm requisite for posterior leukoencephalopathy in patients with primary thunderclap headaches?. Cephalalgia 26 5 (2006) 530-536
25. Calabrese L.H., Dodick D.W., Schwedt T.J., and Singhal A.B. Narrative review: reversible cerebral vasoconstriction syndromes. Ann Intern Med 146 1 (2007) 34-44
26. Rovaris M., Viti B., Ciboddo G., Gerevini S., Capra R., Iannucci G., et al. Brain involvement in systemic immune mediated diseases: magnetic resonance and magnetization transfer imaging study. J Neurol Neurosurg Psychiatric 68 (2000) 170-177